Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice—EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study
Crossref DOI link: https://doi.org/10.1007/s12325-015-0245-x
Published Online: 2015-09-30
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gautier, Jean-Francois
Martinez, Luc
Penfornis, Alfred
Eschwège, Eveline
Charpentier, Guillaume
Huret, Benoît
Madani, Suliya
Gourdy, Pierre
Funding for this research was provided by:
Novo Nordisk (DK)